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Condensation: In this difference-in-differences analysis of births in Scandinavia, there was 51 
no evidence of an impact of COVID-19 mitigation measures on the incidence of preterm 52 
birth.   53 
 54 
Short title: Preterm birth and COVID-19 mitigation measures in Scandinavia 55 
 56 
AJOG at a Glance: 57 
 58 
Why was this study conducted? 59 
 This study aimed to assess the impact of COVID-19 mitigation measures on the 60 
incidence of preterm birth.  61 
 62 
What are the key findings? 63 
 In this difference-in-differences analysis of births in Scandinavia, there was no 64 
evidence of a change in the incidence of preterm birth following the initial 65 
introduction of COVID-19 mitigation measures in 2020.  66 
 67 
What does this study add to what is already known?  68 
 Previous studies have reported conflicting findings. These studies have predominantly 69 
been based on data from healthcare facilities and are potentially underpowered and 70 
unrepresentative, and have not always accounted for temporal trends in preterm birth.  71 
 This analysis of national registry data from three countries with varied levels of 72 
‘lockdown’ provides no evidence of an indirect impact of the COVID-19 pandemic on 73 
preterm birth.   74 












Background: Although some studies have reported a decrease in preterm birth following the 78 
start of the COVID-19 pandemic, findings are inconsistent.  79 
Objective: This study aimed to compare the incidence of preterm birth before and after the 80 
introduction of COVID-19 mitigation measures in Scandinavian countries, using robust 81 
population-based registry data. 82 
Study design: Registry based difference-in-differences study using births from January 2014 83 
through December 2020 in Norway, Sweden and Denmark. Changes in preterm birth (<37 84 
weeks) rates before and after introduction of COVID-19 mitigation measures (set to March 85 
12, 2020) were compared to changes in preterm birth before and after March 12 in 2014-86 
2019. Differences per 1000 births were calculated for 2, 4, 8, 12 and 16 week intervals before 87 
and after March 12. Secondary analyses included medically indicated preterm birth, 88 
spontaneous preterm birth, and very preterm (<32 weeks) birth.  89 
Results: 1,519,521 births were included in this study. During the study period 5.6% of births 90 
were preterm in Norway and Sweden, and 5.7% in Denmark. There was a seasonal variation 91 
in the incidence of preterm birth, with highest incidence during winter. In all three countries, 92 
there was a slight overall decline in preterm births from 2014 to 2020. There was no 93 
consistent evidence of a change in preterm birth rates following the introduction of COVID-94 
19 mitigation measures, with DiD estimates ranging from 3.7/1000 births (95% CI -3.8 to 95 
11.1) for the first two weeks after March 12, 2020, to -1.8/1000 births (95% CI -4.6 to 1.1) in 96 
the 16 weeks after March 12, 2020. Similarly, there was no evidence of an impact on 97 










Conclusions: Using high quality national data on births in three Scandinavian countries, each 99 
of which implemented different approaches to address the pandemic, there was no evidence 100 
of a decline in preterm births following the introduction of COVID-19 mitigation measures. 101 










Introduction  103 
A growing number of studies have attempted to assess the indirect consequences of the 104 
coronavirus disease 2019 (COVID-19) pandemic on key health indicators. It has been 105 
speculated that one of these indirect consequences is an impact on birth outcomes, including 106 
a change in the prevalence of preterm birth. Suggested potential mechanisms for such an 107 
impact include hypothesises about improved air quality (due to strict lockdown measures), 108 
prevention of infections which may otherwise trigger preterm labour1-3; and changes to health 109 
seeking behaviour. On the other hand, pregnant women have experienced added anxiety 110 
about COVID-19 infection, alongside the negative impacts of employment and income 111 
insecurity, home-working, home-schooling and reduced social support.4-6 Additionally, many 112 
settings experienced changes in health care access and availability. 7 A recent meta-analysis 113 
identified 16 studies assessing the impact of the COVID-19 pandemic on preterm birth, 12 of 114 
which were conducted in high-income countries (HIC).8 Although these individual studies 115 
reported conflicting findings, subgroup analysis of the HIC studies suggested some evidence 116 
of a significant decrease in the incidence of preterm birth following the start of the COVID-117 
19 pandemic. Most existing studies are based on data from selected health care facilities or 118 
limited to regional data, and are therefore small, potentially underpowered and not 119 
representative of the general population. Additionally, temporal and seasonal trends in 120 
preterm birth9 have not always been adequately accounted for. There continues to be 121 
insufficient evidence to conclude an impact of COVID-19 mitigation measures on preterm 122 
birth,10 particularly when focusing on longer periods of lockdown and specific preterm birth 123 
subtypes.  124 
Norway, Sweden, and Denmark are similar countries in many ways, particularly in terms of 125 
universal healthcare, levels of income inequality, and fertility patterns. At the time when 126 









2020), COVID-19 rates were similarly low in all three countries. Subsequently, each country 128 
pursued policy measures in attempt to minimise the impact of COVID-19, with both Norway 129 
and Denmark introducing relatively strict lockdown measures in mid-March, while the 130 
approach in Sweden was initially somewhat less restrictive.11-13 All three countries saw 131 
substantial changes in the behaviour of citizens from mid-March onwards with decreasing use 132 
of public transportation, less workplace commuting and more time spent at home.14 The 133 
available behavioural indicators suggest that the strict lockdowns of Norway and Denmark 134 
lockdown translated into larger behavioural changes than in Sweden.15 135 
With national registry-based data from Norway, Sweden and Denmark, we used a difference-136 
in-differences (DiD) design to assess the impact of COVID-19 mitigation measures on the 137 
incidence of preterm birth. 138 
 139 
Materials and Methods 140 
Data sources and study population 141 
Records of births at ≥22 weeks gestation occurring between January 1, 2014 and December 142 
31, 2020 were obtained from the Medical Birth Registry of Norway,16 the Swedish Pregnancy 143 
Register,17 the Danish Medical Birth Register,18 the Danish National Patient Registry,19 and 144 
the Danish Civil Registration System.20 In Norway and Denmark, all births are included in 145 
the registry sources; in Sweden, 92% of births are included in the national register. Further 146 
details of data sources are listed in the appendix (Supplemental Table 1). Births with 147 
multiples were counted as one record only.  148 
 149 










This study was approved by the Regional Committee for Medical and Health Research Ethics 151 
of South/East Norway (#141135), the Swedish Ethical Review Authority (approval numbers: 152 
dnr 2020-01499, dnr 2020-02468, dnr 2021-00274). Each committee provided a waiver of 153 
consent for participants. In Denmark, the study was registered with the Danish Data 154 
Protection Agency via the University of Southern Denmark (reg. no. 364 20/17416) and via 155 
Statistics Denmark. 156 
 157 
Exposure 158 
The DiD design requires a time point on which to split between an unexposed ‘pre’ period 159 
and an unexposed ‘post’ period. Although the intensity and timing of COVID-19 mitigation 160 
measures differed between the three countries, the majority of measures were introduced 161 
around March 12, 2020 (Table 1). Thus, March 12, 2020 was used as the cut-off date for all 162 
three countries. 163 
 164 
Preterm birth 165 
We defined preterm birth as the birth of at least one live or stillborn infant before 37 166 
completed weeks of pregnancy. Preterm birth was further stratified into medically indicated 167 
preterm birth (resulting from induction of labour or a pre-labour cesarean section) or 168 
spontaneous preterm birth (birth after spontaneous onset of labour). We included very 169 
preterm birth (<32 weeks) as an additional outcome. Further details on the definition of 170 
outcomes are included in the appendix (Supplemental Table 1).  171 
 172 










The DiD design mimics experimental methods by comparing changes in an exposed to those 174 
in an unexposed group.21 Specifically, we exploit the exogenous nature of the mid-March 175 
lockdown: Everyone is exposed. However, since the exposure is fixed in time (mid-March 176 
2020) the naïve comparison of before and after the introduction of lockdown measures might 177 
be confounded by any factor that is correlated with time, e.g. seasonal effects or changes in 178 
the characteristics of pregnant women. In the DiD design this is solved by comparing the 179 
changes before and after March 12, not only in 2020, but also in previous years. In this study 180 
we compared the rate of preterm birth in the weeks before and after the introduction of 181 
COVID-19 mitigation measures in 2020 (March 12, difference 1) to the difference in preterm 182 
birth rates before and after March 12 in earlier years (2014-2019, difference 2). The DiD 183 
estimate is the difference between these two differences, obtained using linear probability 184 
models with robust standard errors and presented as a risk difference in points per 1000 185 
births. Statistically, we use an interaction term between pre-post lockdown and year to derive 186 
the DiD estimate. By including year and week fixed effects this approach accounts for 187 
background trends in birth outcomes22, including seasonal trends. The DiD estimate can be 188 
interpreted as the change in birth outcomes that are related to implementation of the COVID-189 
19 mitigation measures in the various countries, beyond background trends in season and 190 
year. If there is no relationship between COVID-19 mitigation measures and subsequent birth 191 
outcomes, then the DiD estimate would be equal to 0. We accounted for clustering by mother 192 
where this information was available (Norway and Sweden). To allow for a time lag between 193 
the introduction of the COVID-19 mitigation measures and a potential impact on preterm 194 
birth, we modelled five different time intervals: 2 weeks after March 12 compared to 2 weeks 195 
before, and similar comparisons for intervals of 4, 8, 12 and 16 weeks. We first ran a model 196 










spontaneous preterm birth, and very preterm birth. The parallel trends assumption was 198 
explored using visual inspection of pre-trends. 199 
Individual data sharing was not possible between countries due to privacy restrictions; 200 
therefore, the DiD analyses were conducted within each country separately according to a 201 
standardized common study protocol. Pooled DiD estimates were generated using a random–202 
effects meta-analysis with inverse variance weighting of individual-country results. 203 
Heterogeneity was assessed using the I2 statistic, calculated as 100% × (Q–df)/Q, where Q is 204 
Cochrane's heterogeneity statistic and df denotes degrees of freedom.23 Analyses were 205 
performed using SAS EG version 9.4 and Stata version 16. 206 
 207 
Results 208 
There were 1,552,401 births between 2014 and 2020 in the three countries. After excluding 209 
32,880 births with missing gestational lengths, gestational age below 22 weeks, unknown 210 
outcome, or second or higher order births from a multiple pregnancy, 1,519,521 births were 211 
included in our study population (392,586 in Norway, 713,121 in Sweden, 413,814 in 212 
Denmark; Supplemental Figure 1). The proportion of preterm birth (<37 completed weeks) 213 
was similar across all three countries, 5.6% in Norway, 5.6% in Sweden, and 5.7% in 214 
Denmark, respectively (Table 2). In all three countries there was a slight decline in the 215 
proportion of preterm birth between 2014 and 2020 (Supplemental Tables 2-4).  216 
Figure 1 presents the weekly incidence (using a three-week rolling average) of preterm birth 217 
between January 2014 and December 2020, with week 11 (which includes the cut-off date, 218 
March 12) indicated by a vertical dashed line. There was a clear general seasonal trend in 219 










observed in late summer and early fall. Notably, in most years the incidence of preterm birth 221 
steadily declined during the first three months of each year. 222 
The DiD analyses included 895,945 births occurring in the period 16 weeks before and after 223 
March 12 from 2014 to 2020 (234,517 in Norway, 421,544 in Sweden, 239,884 in Denmark). 224 
There was no evidence that the parallel trends assumption was violated in any of the three 225 
countries (Supplemental Figure 2). The DiD estimates for preterm birth with different weekly 226 
intervals are presented in Figure 3 (source data in Supplemental Tables 5-7). For all time 227 
intervals there was no discernible difference in the country-specific incidence of preterm birth 228 
after lockdown. There was no evidence of heterogeneity in the meta-analysis, and pooled 229 
estimates did not show an overall decrease across the three countries.  230 
Similarly, when preterm birth was stratified into medically indicated or spontaneous, there 231 
was no convincing difference in country-specific prevalence following March 12, 2020 in 232 
any of the three countries (Figure 4). As with the overall preterm birth analysis, there was no 233 
evidence of heterogeneity and pooled estimates did not provide evidence of a change in the 234 
incidence of either medically indicated or spontaneous preterm birth. 235 
The introduction of COVID-19 mitigation measures had no impact on incidence of very 236 
preterm birth (<32 completed weeks) in any of the three countries (Supplemental Figure 3). 237 
 238 
Comment 239 
Principal findings 240 
We found no convincing evidence to support a change in the incidence of preterm birth 241 
following the introduction of COVID-19 mitigation measures in Norway, Sweden and 242 










decline after lockdown in any of the Scandinavian countries. The findings were similar when 244 
evaluating medically indicated or spontaneous preterm births separately.  245 
Results in the context of what is known 246 
There have been reports of decline in preterm births after the onset of COVID-19 pandemic 247 
in HICs8, 24-36 although findings are inconsistent.37-42 Pooled estimates from a recent meta-248 
analysis suggest a modest decrease in overall preterm birth in HICs only, and also a reduction 249 
in spontaneous preterm birth but not medically indicated preterm birth,8 although the latter 250 
finding rests on results from only two hospital-based studies.25, 37 Notably, an earlier analysis 251 
of Danish data comparing births in the month following lockdown to births in the same 252 
interval in earlier years concluded that there was a decrease in extremely preterm birth after 253 
lockdown, but no similar trend for later preterm births.27 However, this was based on only 254 
one extremely preterm birth recorded for the 2020 study period. A short report comparing 255 
births in Sweden before and after the start of COVID-19 pandemic did not find any 256 
association between birth during the COVID-19 pandemic and preterm birth,42 consistent 257 
with the findings reported here. The general inconsistency in results across previous studies 258 
likely reflects methodological heterogeneity, selection criteria, and lack of ability to minimise 259 
bias caused by existing seasonal and time trends in preterm birth, and also low power for rare 260 
outcomes such as preterm birth subtypes.10 In addition, inconsistencies in results may reflect 261 
heterogeneity in mitigation measures as well as differing population and health system 262 
characteristics.   263 
Although the three Scandinavian countries have similar culture, populations and health care 264 
systems, at the beginning of the pandemic there was a major difference in the approach to 265 
policies and interventions designed to mitigate the COVID-19 pandemic.12, 13 Both the 266 










allowing them to implement domestic restrictions that would otherwise be constitutionally 268 
unlawful. One key difference between the three countries relates to education closures: in 269 
mid-March 2020 all schools were closed in Norway and Denmark, whereas Sweden followed 270 
some days later with only a recommendation for high schools and universities to close. There 271 
was also stronger advice to work from home in both Norway and Denmark. Although the 272 
three countries had similar rates of COVID-19 cases on March 12, by July 2, 16 weeks into 273 
the pandemic, the cumulative confirmed COVID-19 deaths per million people was 46.3 in 274 
Norway, 104.62 in Denmark and 535.8 in Sweden.14 Trust in government is generally high 275 
across all three countries,43 and there is evidence of high compliance with the mitigation 276 
measures which were introduced as a result of the pandemic.44 Adherence to public health 277 
recommendations around social distancing and hygiene almost certainly contributed to an 278 
abrupt end to the 2019/20 influenza season in the three countries,45 with some evidence that 279 
these measures also contributed to a decrease in non-COVID 19 respiratory infections.46 280 
Although there was likely some changes to healthcare in the three countries immediately 281 
following the start of the pandemic, these were likely to predominately be reflected in 282 
reductions in elective care rather than changes in the provision of essential maternal health 283 
services. 284 
While the results from the meta analyses lacked evidence for a decrease in preterm birth for 285 
any of the defined time intervals, it is notable that in Norway estimates were negative 286 
(suggesting a decrease after March 12, 2020) for the overall preterm birth outcome for the 8-, 287 
12- and 16-week intervals. The fact that these trends were only observed for the longer time 288 
intervals following March 12, 2020 in Norway may support the hypothesis of a gradual 289 
change in biological processes that influence preterm birth, rather than any immediate impact 290 
of changes in health care delivery. However, the fact that trends for Denmark - which 291 










hypothesis of some gradual change in the incidence of preterm birth after the introduction of 293 
stricter COVID-19 mitigation measures.  294 
Clinical and research implications 295 
While there are some well-known risk factors for preterm birth, the biological mechanisms 296 
behind preterm birth remain poorly understood.47 and identifying additional factors that could 297 
influence preterm risk is of great interest, as preterm births represent a substantial  burden for 298 
the children themselves, parents and society. Early reports of a decrease in preterm birth 299 
following the onset of the COVID-19 pandemic have therefore ignited much interest,10 and 300 
this is likely in part due to the well-established challenge of further reducing preterm birth 301 
incidence in countries with already low rates of preterm birth.48 Further research could 302 
usefully investigate the extent to which the impact of COVID-19 mitigation measures may be 303 
mediated by contextual factors such as existing trends in preterm birth and characteristics of 304 
health care systems.   305 
Strengths and Limitations 306 
This study used national registry data covering more than 1.5 million births in the three 307 
Scandinavian countries from 2014 through 2020. We captured all births in Norway and 308 
Denmark in this time period, and 92% of births in Sweden. Around 8% of births were 309 
missing due to incomplete electronic data transfer in 3 of Sweden’s 21 counties.17 The 310 
missing registrations did not depend on birth outcomes and would not bias associations. By 311 
comparing births around March 2020 to those in the same seasonal period in previous years, 312 
we were able to account for discernible seasonal and yearly trends in preterm birth. 313 
Prospectively and well-established routine collection of data reduces bias from reporting, and 314 
our primary outcome (preterm birth) is an objective outcome based on gestational age 315 










The COVID-19 pandemic arguably represents the most important natural experiments of our 317 
time, and is well suited to the application of quasi-experimental methods. DiD methods are 318 
designed to minimise the effect of any unmeasured confounding. Nevertheless, unbiased DiD 319 
estimates hinge on the assumption of parallel pre-trends. Visual inspection of plots did not 320 
suggest that the parallel trends assumption was violated. The validity of the approach also 321 
depends on the ‘common shocks’ assumption, which can be defined as the assumption that 322 
any other event that occurs during or following the intervention should affect each group 323 
equally. The common shocks assumption is essentially an untestable assumption involving 324 
any exogenous shocks that may be unknown. However, the use of data from three countries, 325 
with comparable findings suggest that this is not the cause of our findings.   326 
A strength of our study was that we were able to subdivide preterm birth into those with 327 
spontaneous onset and medically indicated. We were also able to assess very preterm birth 328 
(<32 weeks) as a standalone outcome. However, the number of country-specific events by 329 
week was insufficient to assess any impact on less common preterm birth subtypes, such as 330 
extremely preterm birth (<28 completed weeks). We were therefore unable to use our DiD 331 
approach to confirm the suggested decreased incidence of extremely preterm birth found in a 332 
previous Danish study.27   333 
The aim of this study was to assess the indirect consequences of the COVID-19 pandemic on 334 
preterm birth, and we therefore did not include information on SARS-CoV-2 infection in 335 
pregnancy. There is emerging evidence that SARS-CoV-2 infection is associated with an 336 
increased risk of preterm birth.49, 50 However, given the generally low level of testing among 337 
asymptomatic and mild cases, these findings predominantly relate to more severe infections, 338 
so it is expected that confounding by indication will bias the estimates towards an 339 










Scandinavia is likely to be minimal, given the still comparatively low rates of infection in 341 
these countries during the study period. 342 
 343 
Conclusion 344 
The indirect impacts of the COVID-19 pandemic are far-reaching and still only beginning to 345 
be understood.  Using robust population-based data from three high-income countries with 346 
varying levels of COVID-19 mitigation measures, we found no strong evidence of a decline 347 
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Table 1. Summary of early COVID-19 mitigation measures in Norway, Sweden and 476 
Denmark 477 
 Norway Sweden Denmark 
Kindergarten/daycare  
and primary schools 
closed 
March 12 n/a March 16 
High school and 
universities closed 
March 12 March 17 
(recommendation) 
March 13  
Restrictions on 
gathering 
March 12 March 11 (500+) 
March 27 (50+) 
March 11 (100+) 
March 17 (10+) 
Workplace closures March 10 
(recommendation to 
work from home) 
March 16 
(recommendation to 
work from home) 
March 13 (Non-
essential workers in 
public sector ordered 
to stay home, private 




Some closures from 
March 12 
 Some closures from 
March 18, including 
restaurants/bars 
Stay at home 
recommendations 
March 12 Avoid public 
transport and 
unnecessary travels,  
March 19 not allowed 
to spend night in 
vacation homes 
outside home county 
March 16 for over 70s 
March 19 Avoid 
unnecessary travels    
 
 March 11 restrict 
public transport and 















isolation if symptoms 
March 14 Advice 
against all 
international travels, 
isolation and get 
tested if symptoms 
after arrival to Sweden  
March 11 
(flights from high-risk 
areas cancelled) 




March 12 March 12 March 13 
 478 









Table 2. Characteristics of included births 2014-2020, Norway, Sweden and Denmark 480 
  Norway   Sweden  Denmark 
  n  (%)   n  (%)  n  (%) 
All births 392,586   713,121   413,814  
         
Gestational age         
Extremely preterm <28 weeks 1449 (0.4)  2670 (0.4)  1620 (0.4) 
Very preterm 28-<32 weeks 2123 (0.5)  3912 (0.5)  2393 (0.6) 
Moderate/late preterm 32-<37 weeks 18,256 (4.7)  33,264 (4.7)  19,411 (4.7) 
Term 37-<42 weeks 354,821 (90.4)  636,182 (89.2)  381,218 (92.1) 
Post-term ≥42 weeks 15,937 (4.1)  36,113 (5.1)  9172 (2.2) 
Maternal age          
  <20 3710 (0.9)  7266 (1.0)  3296 (0.8) 
  20-24 41,279 (10.5)  75,668 (10.6)  41,652 (10.1) 
  25-29 126,280 (32.2)  223,444 (31.3)  138,920 (33.6) 
  30-34 139,841 (35.6)  246,949 (34.6)  144,304 (34.9) 
  35-39 66,785 (17.0)  128,099 (18.0)  69,390 (16.8) 
  ≥40 14,690 (3.7)  31,484 (4.4)  16,252 (3.9) 
Missing 1 (0.0)  211 (0.0)    
Parity          
0 166,742 (42.5)  306,085 (42.9)  190,650 (46.1) 
≥1 225,844 (57.5)  402,892 (56.5)  223,120 (53.9) 
Missing    4144 (0.6)  44 (0.0) 
Multiple birth         
Yes 6107 (1.6)  10,072 (1.4)  6768 (1.6) 
No 386,479 (98.4)  703,049 (98.6)  407,046 (98.4) 
Season of conceptiona         
  Winter  90,360 (23.0)  186,013 (26.1)  105,919 (25.6) 
  Spring  92,381 (23.5)  189,348 (26.6)  97,751 (23.6) 
  Summer  102,690 (26.2)  170,177 (23.9)  100,506 (24.3) 
Fall  107,155 (27.3)   167,583 (23.5)  109,638 (26.5) 











Figure 1. Incidence of preterm birth by weeka, 2014-2020, Norway, Sweden and Denmark 




Figure 2. Percent difference in preterm birth in the weeks before and after March 12a, comparing 
births in 2020 to births in 2014-2019, Norway, Sweden and Denmark 
aWeek beginning March 12 represented by a dashed vertical line 
 
 




Figure 4. Meta analyses of DiD estimates for a) medically-indicated preterm birth and b) 
spontaneous preterm birth 
 
 
 
Jo
urn
al 
Pr
e-p
roo
f
Jo
urn
al 
Pr
e-p
roo
f
Jo
urn
al 
Pr
e-p
roo
f
Jo
urn
al 
Pr
e-p
roo
f
Jo
urn
al 
Pr
e-p
roo
f
